首页 正文

Plasma SuPAR and therapeutic response to erenumab in migraine: a REFORM study

{{output}}
Background: Soluble urokinase-plasminogen activator receptor (suPAR) is a biomarker of systemic inflammation and elevated in plasma of individuals with migraine with aura. As inflammatory cytokines can upregulate calcitonin gene-... ...